Morning Market Losers By: Benzinga via Benzinga May 07, 2014 at 09:48 AM EDT Corcept Therapeutics (NASDAQ: CORT) declined 50.50% to $1.99 following earnings miss and drug trial halt. Oclaro (NASDAQ: OCLR) ... Read More >> Related Stocks: Corcept Therapeutics Extreme Networks Fireeye Inc Groupon Cl A Oclaro Trimble Navigation Whole Foods Market